close
close
news

Orelvis Martinez has been suspended 80 games for violating the MLB performance-enhancing drug policy

Toronto Blue Jays prospect Orelvis Martinez, who made his big league debut on Friday, has been suspended for 80 games for violating MLB’s performance-enhancing drug policy, the league announced Sunday. Martinez tested positive for Clomiphene, a performance-enhancing drug. The suspension takes effect immediately.

“The Blue Jays fully support Major League Baseball’s Joint Drug Prevention and Treatment Program and strongly believe in maintaining a level playing field,” Blue Jays EVP and General Manager Ross Atkins said in a statement. “We were both surprised and disappointed to hear of Orelvis Martinez’s suspension. We will do everything we can to ensure that Orelvis learns from this mistake.”

Martinez said he and his girlfriend visited a fertility clinic in the Dominican Republic during the off-season, where he was prescribed a drug called Rejun 50, which contains the banned substance Clomiphene. Martinez said it was a “mistake” not to disclose this to the Blue Jays or the MLBPA.

“I took full responsibility for my actions and accepted my suspension,” Martinez said in a statement. “I would like to apologize to my teammates in both Buffalo and Toronto, the Blue Jays organization and, most importantly, the fans who have supported me throughout my career.”

In the wake of his suspension, Martinez has been placed on the restricted list and the Blue Jays have recalled OF Steward Berroa from Triple-A Buffalo.

Martinez, 22, is the Blue Jays’ No. 2 prospect and one of the best young players in their system. He was called up when Blue Jays shortstop Bo Bichette went on the IL with a right calf strain.

Martinez, who ranks 43rd The Athletics‘s Keith Law’s latest MLB top-50 prospect list turned heads for his powerful bat. In 63 games with Triple-A Buffalo, Martinez hit .260/.343/.523 with 16 home runs.

This story will be updated.

(Photo: Frank Jansky/Icon Sportswire via Getty Images)

Related Articles

Back to top button